CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 59 filers reported holding CARDIFF ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $72 | -99.8% | 52 | -99.8% | 0.00% | – |
Q3 2022 | $46,000 | -37.0% | 29,996 | -9.2% | 0.00% | -100.0% |
Q2 2022 | $73,000 | -28.4% | 33,038 | +115.4% | 0.00% | 0.0% |
Q2 2021 | $102,000 | -81.9% | 15,335 | -74.7% | 0.00% | -88.9% |
Q1 2021 | $562,000 | -67.6% | 60,647 | -37.1% | 0.01% | -64.0% |
Q4 2020 | $1,735,000 | – | 96,445 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 2,522,083 | $16,797,000 | 13.61% |
Octagon Capital Advisors LP | 982,753 | $6,545,000 | 1.61% |
Altium Capital Management LP | 348,888 | $2,324,000 | 0.61% |
ACT CAPITAL MANAGEMENT, LLC | 102,500 | $683,000 | 0.35% |
Eventide Asset Management | 1,670,399 | $11,125,000 | 0.15% |
Artal Group S.A. | 750,000 | $4,995,000 | 0.11% |
Virtus ETF Advisers LLC | 25,770 | $172,000 | 0.08% |
HighVista Strategies LLC | 15,501 | $103,000 | 0.07% |
ELKHORN PARTNERS LIMITED PARTNERSHIP | 13,500 | $90,000 | 0.05% |
SCHOLTZ & COMPANY, LLC | 16,625 | $111,000 | 0.04% |